Related Experiment Videos
The new biology of cancer: future clinical applications
1Department of Medicine, University of Missouri School of Medicine, Columbia 65212.
Abstract:
Our recognition that cancer evolves by clonal selection and that the basis for this selection is the growth advantage provided by the inappropriate expression or suppression of genes present in all normal cells allows us to anticipate that the pathways of this evolutionary process may be discovered. If a finite number of such pathways exist with some commonality between various tumors, there is the possibility to anticipate the mechanisms that cell clones might use for both carcinogenesis and tumor progression and to deal with evolving clones before their survival potential becomes overwhelming. As our biochemical understanding increases we may develop the capability to do the following: to identify individuals who have inherited or acquired defective cancer suppressor genes; to identify precursor lesions more exactly; to characterize the degree of progression of a newly diagnosed tumor (has the metastatic phenotype evolved?); to develop antibodies against cell membrane proteins necessary to tumor progression; to produce immune probes that carry cytotoxins or isotopes to specific cell populations; and to take advantage of cell signals to modify tumor growth. The potential for application of the New Biology to cancer medicine seems endless.
Insights
Cancer evolves through clonal selection driven by gene expression changes. Understanding these pathways may lead to early detection and targeted therapies for cancer progression.
Area of Science:
- Oncology
- Molecular Biology
- Genetics
Background:
- Cancer progresses via clonal selection, driven by altered gene expression in normal cellular genes.
- Understanding cancer evolution pathways is crucial for developing effective therapeutic strategies.
Purpose of the Study:
- To explore the potential for discovering cancer evolution pathways.
- To anticipate mechanisms of carcinogenesis and tumor progression.
- To identify new therapeutic strategies based on cancer biology.
Main Methods:
- Conceptual framework based on clonal selection and gene expression.
- Biochemical and molecular understanding of cancer development.
- Anticipation of future diagnostic and therapeutic applications.
Main Results:
- Cancer evolution follows identifiable pathways driven by gene expression.
- Common pathways may exist across different tumor types.
- Increased biochemical understanding enables new clinical capabilities.
Conclusions:
- Discovering cancer evolution pathways offers opportunities for early intervention.
- New Biology applications in cancer medicine are extensive.
- Targeting cancer's evolutionary mechanisms can combat tumor progression.